INNOVATIONS in pharmacy

Value Assessment in Cystic Fibrosis: ICER’s Rejection of the Axioms of Fundamental Measurement

Paul Langley

University of Minnesota

DOI: https://doi.org/10.24926/iip.v11i2.3248

Keywords: fundamental measurement, ICER beliefs, impossible QALYs, rejecting value, fantasy claims

---

Abstract

One of the features of the ICER stakeholder involvement in the development of ICER evidence reports is the ability for public comment. Unfortunately, and this may just a miscommunication, the replies from ICER to public comments frequently miss the point or fail to provide backup for their claims. The purpose of this commentary is to review ICER’s responses to public comments by the author on the just released final evidence report on cystic fibrosis. The message is quite simple: the ICER value assessment framework lacks credibility. It fails to meet the standards of normal science. This is seen in ICERs apparent ignorance or rejection of the axioms of fundamental measurement which point quite clearly to the mathematical impossibility of creating QALYs from generic multiattribute utility scores. The ICER report also fails standards by creating a model from prior assumptions; there is no logical basis for constructing a value assessment claim. Either ICER should withdraw its value claims or admit the dubious basis on which the model is built, as a duty to its readership.

 

Article Type: Commentary